why choose us

First received: November 22, 2022

Clinical Trial: A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Adrenocortical Carcinoma

Study Type: INTERVENTIONAL


Official Title: A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma

Brief Summary: To learn if adding pembrolizumab to mitotane can help to control ACC.The safety of this drug combination will also be studied.

Read more